Best Patient Panel Providers in Poland for Clinical & Market Research
8 patient panel providers in Poland, scored in 2026 on sample verification, fraud prevention and compliance, with the best use case for each.
Quick answer
For specialist rare-disease and caregiver studies, Global Vox Populi is the primary choice. For large-scale physician and patient research, M3 Global Research and Ipsos offer global scale. For local Polish fieldwork expertise, Stratega Research and AQR Fieldwork provide tailored support for qualitative and quantitative data collection.
Securing accurate, compliant, and representative data from Polish patients is a critical hurdle for life sciences organizations operating in Central Europe. As the regulatory environment for health data becomes more stringent, the role of reliable patient panel providers in Poland has moved from a tactical convenience to a core strategic requirement.
Decision-makers now face a fragmented market where global scale often competes with local nuance. Understanding the differences in recruitment, verification, and data protection is essential for making sure that clinical and market research outcomes are both actionable and ethically sound. This assessment reviews eight providers based on their ability to handle the specific requirements of Polish healthcare studies, ranging from therapeutic-area coverage to the management of sensitive patient information.
Best Patient Panel Providers in Poland for Clinical & Market Research: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | End-to-end clinical development and data modeling | 86.0 |
| 2 | Ipsos | Large-scale societal and healthcare tracking studies | 82.5 |
| 3 | Global Vox Populi | Rare-disease patient and caregiver research | 82.5 |
| 4 | M3 Global Research | Global physician and patient research at scale | 82.5 |
| 5 | Stratega Research | Full-service qualitative and quantitative healthcare fieldwork | 76.0 |
| 6 | AQR Fieldwork | Targeted healthcare recruitment for qualitative studies | 73.5 |
| 7 | BioStat | Statistical analysis and data-driven healthcare research | 68.0 |
| 8 | PMR Market Experts | Strategic market analysis in the CEE region | 58.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Physicians, patients, and healthcare organizations | Professional registry checks and clinical database validation | Not stated on pages reviewed | Project quote | Not published | Not published |
| Ipsos | Citizens, consumers, patients, and healthcare professionals | Authentication of proprietary panelists | Not stated on pages reviewed | Project quote | Not published | Not published |
| Global Vox Populi | Patients, caregivers, physicians, and nurses | Multi-stage validation, identity fingerprinting, and registration checks | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 1,005,227 patient profiles; 20,100 caregivers (in Poland; Global Vox Populi panel records, Oct 2026) | Not published |
| M3 Global Research | Physicians and patients | ISO certified verification and annual audits | ISO 20252, ISO 27001 | Project quote | Not published | Not published |
| Stratega Research | Physicians, pharmacists, and patients | Advanced quality check and professional validation system | ESOMAR | Project quote | Over 17,000 healthcare professionals (strategaresearch.com, Oct 2026) | Not published |
| AQR Fieldwork | Patients, caregivers, physicians, and lab technicians | Project-specific screening and professional verification | Not stated on pages reviewed | Project quote | Not published | Not published |
| BioStat | General consumers and medical patients | Profile validation and fraud prevention systems | Not stated on pages reviewed | Per complete | Not published | Not published |
| PMR Market Experts | Medical professionals and healthcare stakeholders | Professional registry and stakeholder verification | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| Ipsos | ● | ● | ● | ● | – | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Stratega Research | ● | ● | ● | ● | ● | – |
| AQR Fieldwork | ● | ● | – | ● | ● | ● |
| BioStat | ● | – | ● | ● | – | – |
| PMR Market Experts | ● | – | ● | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their capability to deliver high-integrity healthcare research data within the specific regulatory and demographic environment of Poland.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This measures the origin of respondents and the rigor applied to verifying their health status and credentials. Good providers use proprietary panels, not open exchanges, and employ multi-stage validation for patients and physicians. In Poland, this requires checking professional registries and managing patient consent with high precision. |
| Compliance, Certifications and Security | 20 | This assesses adherence to ISO standards, GDPR, and medical research codes like BHBIA. High-performing firms demonstrate documented protocols for adverse event reporting and data security. For Polish research, evidence of ISO 27001 and strict data handling is mandatory for projects involving sensitive medical information and patient records. |
| Target Audience Reach | 15 | This evaluates the depth of access to specific patient cohorts, caregivers, and HCPs. A strong provider offers granular profiling across many therapeutic areas and successfully recruits low-incidence populations. In Poland, the ability to reach representative patient groups across different regions and specialties is a key differentiator. |
| Data Quality and Fraud Prevention | 10 | This looks at the technical controls implemented to protect respondent honesty. Effective systems include device fingerprinting, trap questions, and straight-lining detection. For Polish healthcare studies, these controls must be sophisticated enough to distinguish between genuine patients and those attempting to bypass screening for participation incentives. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This identifies the range of research tools available, from digital surveys to in-person ethnography. A capable provider offers a mix of quantitative data collection and qualitative depth, such as IDIs or focus groups. This is essential for understanding the nuance of the Polish healthcare market and patient journeys. |
| Client Service and Speed | 5 | This measures responsiveness and the ability to manage complex project timelines. It covers how a provider communicates throughout the fieldwork phase and their flexibility in addressing unforeseen challenges. Reliable partners in Poland provide proactive updates and maintain clear, consistent communication with the research team. |
| Pricing and Feasibility Transparency | 5 | This assesses the honesty and clarity of the provider regarding project costs and timelines. A good partner provides detailed feasibility estimates early, identifying potential risks to sample size or timing before the research commences. This prevents scope creep and makes sure the project remains aligned with budget expectations. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: patient panel providers in Poland
IQVIA: best for end-to-end clinical development and data modeling
Strongest fitLarge-scale pharmaceutical companies needing clinical trial support and real-world evidence generation.
IQVIA is a global entity with a significant footprint in Poland, focusing on accelerating clinical trials and improving patient outcomes through data-driven intelligence. Their service model integrates clinical development with advanced analytics, helping life sciences companies work through complex regulatory environments.
The company specializes in large-scale data and technology solutions, including predictive clinical development and real-world evidence generation. Their approach is heavily focused on the efficiency of clinical trials and the optimization of asset performance for pharmaceutical and biotech clients.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Clinical Development Solutions: Full-service clinical trials and site management, including functional service provider models.
- Real-World Evidence: Generation of evidence to support market access and patient outcome improvements.
- Data Analytics: Application of AI and predictive models to optimize clinical development and commercial execution.
Strengths
- Data Depth: Access to petabytes of proprietary, non-identified patient records and extensive clinical trial site intelligence.
- Regulatory Expertise: Specialized teams focused on pharmacovigilance and protecting compliance during complex clinical trial operations.
- Technological Infrastructure: Advanced AI platforms designed to connect data, technology, and analytics for trial optimization.
Innovation and technology
- IQVIA.ai Platform: Uses agentic AI to predict trial outcomes and optimize clinical development processes.
- Predictive Clinical Development: Models designed to accelerate trial timelines and reduce risks in asset development.
Impact on businesses
- Asset Maximization: Supports pharmaceutical companies in maximizing the probability of success for their assets.
- Operational Efficiency: Reduces lag times and improves quality in trial management through integrated, flexible outsourcing.
Why it may fit your brief
IQVIA fits well for high-stakes, large-scale clinical trials where data integration is essential. For smaller, qualitative market research projects, their large-scale clinical focus may be less tailored than boutique agencies.
Ipsos: best for large-scale societal and healthcare tracking studies
Strongest fitGlobal healthcare organizations needing large-scale, representative tracking and societal insights.
Ipsos maintains a significant presence in Poland, using its global scale and specialized healthcare service units. They are focused on delivering actionable insights into society and health, supporting pharmaceutical and healthcare organizations with large-scale tracking and patient perception studies.
The company uses advanced survey technology and vast proprietary panels to protect high-quality data. Their work is characterized by a commitment to ethical standards and the application of sophisticated research methodologies to complex healthcare topics.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Healthcare Tracking: Long-term monitoring of healthcare system perceptions and public health issues.
- Market Strategy: Strategic understanding of healthcare markets and brand health tracking.
- Qualitative Research: Deep-dive qualitative insights through Ipsos UU and online communities.
Strengths
- Global Scale: Access to massive, authenticated proprietary panels across global markets.
- Methodological Breadth: Combines surveys, social media listening, and qualitative insights for a holistic view.
- Ethical Standards: Demonstrates strong commitment to objective, ethical research principles and data security.
Innovation and technology
- AI Integration: Uses AI to analyze complex datasets and deliver actionable truths for clients.
Impact on businesses
- Evidence-Based Decisions: Provides reliable information that helps healthcare leaders make confident, smarter decisions.
Why it may fit your brief
Ipsos is a top choice for large, longitudinal studies requiring global consistency. For hyper-local, niche patient recruitment, a smaller, more agile boutique agency might be more appropriate.
Global Vox Populi: best for rare-disease patient and caregiver research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitResearch teams requiring high-integrity data for sensitive or low-incidence patient and caregiver studies in Poland.
Global Vox Populi operates as an independent primary market research firm, maintaining its own proprietary healthcare panels rather than relying on external rental markets. Their presence in Poland is defined by a large, deeply profiled database that supports both quantitative and qualitative research across a wide spectrum of therapeutic areas.
The provider emphasizes strict data integrity, using multi-layered verification and de-duplication to make sure that the respondents recruited are authentic. Their approach is designed for researchers who require high-precision targeting for complex studies, such as those involving rare diseases or specific patient-caregiver dynamics, while maintaining compliance with international health data standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Patient panel, in Poland
1,005,227 patient profiles
- Aesthetics & Cosmetic321,141
- Cardiovascular84,453
- Ophthalmology57,645
- Endocrinology & Metabolic53,998
- Dermatology49,443
- Women's Health47,643
Across 731 conditions; a patient with more than one condition is counted once per condition.
Caregivers panel, in Poland
20,100 panellists
- Spouse / Partner4,593
- Adult Child > Parent/Elderly6,874
- Parent > Child w/ Condition1,797
- Sibling961
- Grandchild <> Grandparent931
- Other Family1,195
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Proprietary Panel Access: Direct access to a patient panel and caregivers across 199 global markets.
- Healthcare Research Solutions: Comprehensive healthcare market research including support for adverse event reporting and product complaints.
- Qualitative Research Tools: Specialized in-depth interview services and online research communities for deeper patient insight.
Strengths
- Deep Patient Profiling: Access to 1,005,227 patient profiles in Poland, with 20,100 additional panellists in its caregivers segment for targeted recruitment.
- Rigorous Data Quality: Employs device fingerprinting, identity checks, and completion-quality scoring to remove fraudulent completes before data delivery.
- Regulatory Compliance: Maintains ISO 9001, 20252, and 27001 certifications, making sure all research is conducted under strict HIPAA and GDPR-aligned data protection frameworks.
Innovation and technology
- Advanced Targeting Tech: Uses mobile and WhatsApp-assisted survey tools to improve respondent engagement in hard-to-reach patient populations.
- Validation Systems: Uses rolling validation of medical credentials and identity for clinical members to maintain the integrity of its proprietary database.
Impact on businesses
- Actionable Clinical Insights: Helps clients refine treatment pathways and patient support programs through granular data on 27 therapeutic areas.
- Risk Mitigation: Protects reliable research outcomes by identifying and reporting adverse events in accordance with established medical research guidelines.
Why it may fit your brief
The provider is well-suited for briefs needing deep profiling and verified respondents. For projects requiring only general population consumer data, a larger, less specialized panel provider might be more cost-effective.
M3 Global Research: best for global physician and patient research at scale
Strongest fitGlobal pharmaceutical and biotech firms requiring large-scale, verified physician and patient insights.
M3 Global Research is a prominent global operator with extensive panel coverage in Europe, including Poland. They focus on delivering solid quantitative and qualitative research for pharmaceutical and biotech clients, underpinned by high-quality data and stringent compliance.
The company uses its ISO-certified proprietary panel to provide deep access to both physicians and patients. Their service model is built on providing volume alongside quality, making sure that clients receive actionable insights that can improve global patient outcomes.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Healthcare Fieldwork: Full-service quantitative and qualitative research fieldwork for life sciences.
- Physician Panel: Access to the world’s largest proprietary panel of verified healthcare professionals.
- Data Quality Assurance: Strict fraud prevention and data quality measures for global research projects.
Strengths
- Panel Quality: ISO 20252 certification for their physician panel confirms high-quality data standards.
- Information Security: Holds ISO 27001 certification, evidencing a commitment to stringent data security.
- Global Reach: Capability to deliver research across over 70 markets with integrated panel access.
Innovation and technology
- Technology-Led Research: Layers innovation and technology with deep industry knowledge to support remote methodologies.
Impact on businesses
- Improved Patient Outcomes: Delivers insights that help clients drive better decisions in global healthcare research.
Why it may fit your brief
M3 is ideal for large-scale, high-quality studies needing broad reach. For small-scale, deeply localized qualitative studies in Poland, a local agency might offer more nuanced support.
Stratega Research: best for full-service qualitative and quantitative healthcare fieldwork
Strongest fitPharma and medical companies requiring both high-quality qualitative fieldwork and large-scale quantitative data.
Stratega Research operates as a full-service market research provider with a strong emphasis on healthcare and B2B segments in Poland and Eastern Europe. They combine proprietary panels with local fieldwork teams to deliver comprehensive research solutions.
The company is well-known for its ability to handle complex qualitative projects, offering viewing facilities and moderation services. Their healthcare panel is particularly solid, focusing on verified physicians and patients to meet the stringent requirements of pharmaceutical and medical device clients.
Scorecard: 76.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.0 |
Core services
- Healthcare Panel: Access to a large, verified panel of healthcare professionals and patients.
- Qualitative Facilities: Viewing facilities and moderation services for focus groups and IDIs.
- Data Collection: Execution of CATI, CAPI, and online research projects across Eastern Europe.
Strengths
- Verified Medical Panel: Maintains a panel of over 17,000 healthcare professionals with strict validation procedures.
- Regional Reach: Strong presence in Poland and across Eastern Europe with native-language moderators.
- Compliance Focus: Strict adherence to ESOMAR standards and healthcare-specific data protection requirements.
Innovation and technology
- Ethnographic Techniques: Uses home-based ethnographic observations to understand patient behavior in their natural environment.
Impact on businesses
- Strategic Market Insights: Supports pharmaceutical marketing and medical device positioning with reliable, compelling data.
Why it may fit your brief
Stratega is ideal for projects needing local moderation and viewing facilities. For studies that are purely digital and global, their regional, facility-based model may be more intensive than required.
AQR Fieldwork: best for targeted healthcare recruitment for qualitative studies
Strongest fitResearchers needing specific, hard-to-reach patient or professional cohorts for qualitative healthcare studies.
AQR Fieldwork is a dedicated data collection and recruitment agency that emphasizes quality and precision in reaching niche audiences. They are particularly active in the healthcare sector, recruiting patients, caregivers, and various healthcare professionals for qualitative and quantitative research.
The company focuses on managing the entire fieldwork process, from participant identification to data reporting. Their approach is designed to provide clients with access to specific, hard-to-reach target groups, using both proprietary panels and custom recruitment strategies.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Healthcare Recruitment: Targeted recruitment of patients, caregivers, and medical professionals.
- Qualitative Fieldwork: Management of focus groups, IDIs, and online bulletin boards.
- Quantitative Data Collection: Execution of surveys and central location tests.
Strengths
- Specialized Access: Expertise in reaching niche healthcare groups, including KOLs and specialists.
- Operational Flexibility: Offers diverse data collection methods, including F2F and telephonic interviews.
- Quality Control: Adheres to international research standards for participant recruitment and integrity.
Innovation and technology
- CATI Capabilities: Advanced telephonic interview setup for reaching difficult audiences where online methods are limited.
Impact on businesses
- Actionable Insights: Provides high-quality data collection that translates into clear, actionable research reporting.
Why it may fit your brief
AQR is a strong partner for qualitative research recruitment and niche audience access. For massive-scale quantitative patient studies, a larger panel provider might be more efficient.
BioStat: best for statistical analysis and data-driven healthcare research
Strongest fitPharma and medical companies needing solid statistical analysis and rapid online survey fieldwork.
BioStat functions as a specialized R&D center and CRO, focusing on the rigorous statistical and analytical aspects of healthcare research in Poland. They provide comprehensive services for clinical trials and market research, using their own panel of respondents.
The company maintains a significant internet panel, allowing for rapid data collection across various demographics. Their expertise lies in the application of statistical methods to medical data, supporting both academic and commercial research initiatives with high technical accuracy.
Scorecard: 68.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Weighted score | 100 | 68.0 |
Core services
- Clinical Research Services: Full CRO support including data management and clinical trial methodology.
- Market Research: Survey-based market research and opinion polling for the pharma and medical sectors.
- Statistical Analysis: Advanced data processing and statistical modeling for healthcare and academic projects.
Strengths
- Technical Rigor: Strong foundation in medical statistics and rigorous research methodology.
- Panel Speed: Offers rapid survey execution through their proprietary panel of over 200,000 respondents.
- Multimodal Capability: Supports multimedia survey content, including audio-visual materials for product and concept testing.
Innovation and technology
- Mobile-First Surveys: Optimized for mobile device completion to protect respondent convenience and data accessibility.
- Advanced Validation: Uses automated checks to protect respondent reliability and to prevent fraudulent account creation.
Impact on businesses
- Data-Driven Strategy: Provides clear statistical insights to guide product development and marketing for pharma firms.
Why it may fit your brief
BioStat excels in projects requiring statistical precision and fast online turnaround. For in-depth, high-touch qualitative research, other agencies with dedicated viewing facilities may offer more comprehensive support.
PMR Market Experts: best for strategic market analysis in the CEE region
Strongest fitHealthcare organizations seeking strategic market data and regional intelligence in Poland.
PMR is a long-established research and consulting firm with a strong focus on the pharmaceutical and healthcare markets in Poland and the broader CEE region. Their work centers on delivering data-driven insights to support strategic decision-making for stakeholders in the healthcare network.
The company maintains panels of medical professionals and healthcare stakeholders, providing analysis that helps clients understand market dynamics and competitive positioning. Their focus is primarily on market intelligence and strategic consulting rather than clinical trial recruitment.
Scorecard: 58.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 6/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 5/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 5/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | pmr.pl (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 58.0 |
Core services
- Market Analysis: Strategic intelligence regarding pharmaceutical and healthcare markets in Poland.
- Competitive Intelligence: Analysis of market competitors and industry trends for health-related businesses.
- Strategic Consulting: Consulting services to assist with market entry and growth strategies in the CEE region.
Strengths
- Regional Expertise: Deep understanding of the CEE pharmaceutical environment and healthcare market structure.
- Consulting Focus: Provides actionable strategic advice based on collected market data.
- Stakeholder Access: Established panels of medical professionals and key healthcare stakeholders.
Innovation and technology
- Data-Driven Modeling: Uses market data to create projections and insights for pharmaceutical market participants.
Impact on businesses
- Strategic Decision Support: Enables companies to make informed decisions regarding market positioning and commercial strategy.
Why it may fit your brief
PMR is an excellent fit for strategic consulting and broad market intelligence. For tactical patient recruitment or specific clinical research studies, a provider with a larger proprietary patient panel might be more effective.
How patient panel verification actually works in Poland
Demand documented proof of respondent identity, professional registration, and condition validation for every healthcare research project.
Professional Credential Verification
For studies targeting physicians and allied health professionals, providers must verify medical licenses against official state or professional registries. Ask the provider for their specific process for re-validating credentials on a rolling basis, rather than relying on self-reported data. If a provider cannot produce evidence of this validation, the risk of including non-verified or fraudulent respondents is high.
Patient Condition Validation
Validating that a patient actually has a specific medical condition is complex. High-quality providers use multi-stage screening that includes specific medical history questions, proof of prescription, or diagnosis verification. Request to see the screening questionnaire and understand how they manage potential false positives, as these can drastically skew your research results.
Data Integrity and De-duplication
Identity fraud is a common issue in online research. Protect the provider uses device fingerprinting, geo-location checks, and identity verification to prevent professional survey-takers from participating. Ask for a report on how they handle IP addresses and if they use trap questions to identify respondents who are not paying attention to the survey content.
Regulatory Compliance Reporting
In healthcare, verifying that a provider understands the reporting requirements for adverse events is essential. Make sure they have a formal process for identifying and reporting these events to your pharmacovigilance team. Request a copy of their standard operating procedure for handling such reports to protect full compliance with health data laws.
How to choose the right provider in Poland
Select a provider based on the specific requirements of your research brief, balancing the need for large-scale quantitative data with the requirement for deep, nuanced qualitative recruitment.
- Define Data Requirements: Determine whether you need broad representative data or niche, low-incidence patient groups. This will clarify if you need a global panel provider or a boutique agency specialized in local recruitment.
- Check Regulatory Standards: Prioritize firms with ISO 27001 and 20252 certifications. These standards indicate a high level of rigor in data security and research quality, which is essential for sensitive health data.
- Assess Verification Methods: Request a detailed explanation of how they verify respondent identity and medical status. A transparent, multi-stage process is a hallmark of a reliable healthcare research partner.
- Request Feasibility Reports: Ask for a feasibility check early in the process. A good provider will be honest about whether they can meet your sample requirements within your timeline.
- Evaluate Local Depth: If your research requires local knowledge of Polish healthcare structures, make sure the provider has local teams or experts. This makes sure that survey design and recruitment are culturally and medically relevant.
Questions to ask before you commission
- What specific methods do you use to verify that a patient actually has the medical condition required for this study?
- Can you provide your current ISO certifications and explain how they relate to the security of the health data you collect?
- How often do you re-validate the professional credentials of your healthcare professional panel members?
- What specific fraud-prevention technologies do you employ to make sure our survey data is not compromised by bots or duplicates?
- What is your standard operating procedure for reporting adverse events or product complaints during fieldwork?
- Can you provide a feasibility report for our specific target audience in Poland before we sign the project agreement?
Common pitfalls to avoid
- Over-reliance on Open Exchanges: Relying on providers that aggregate respondents from open sample exchanges often leads to lower data quality and higher fraud risks. Always prioritize firms that own and manage their own proprietary panels.
- Ignoring Local Regulations: Assuming that global data protection standards are sufficient without considering local Polish law can lead to significant compliance issues. Always make sure the provider is fully compliant with local health data regulations.
- Lack of Feasibility Planning: Failing to demand a feasibility check for hard-to-reach patient groups often results in missed deadlines and incomplete data sets. Never assume a panel can reach every niche audience without evidence.
- Poor Adverse Event Handling: Neglecting to align the research provider with your pharmacovigilance team's requirements can create legal and regulatory risks. Always confirm the provider's capability to report adverse events.
What a feasibility check should include
A rigorous feasibility check should provide concrete evidence of the provider's ability to reach your specific audience within your required timeframe.
Audience Depth Analysis
The provider should confirm they have the required number of panellists who meet your specific inclusion criteria. This prevents the common mistake of assuming a large total panel size equates to sufficient reach for niche conditions.
Incidence Rate Estimation
A good feasibility check includes an honest estimate of the incidence rate for your target population. This helps in planning the recruitment budget and avoids unrealistic expectations.
Timeline Realism
The provider must outline the realistic duration for recruitment and data collection based on their past experience with similar studies. This makes sure your project schedule remains grounded in operational reality.
Potential Risk Identification
The check should identify potential hurdles, such as seasonal recruitment issues or regulatory constraints, that could impact the speed or quality of the research.
Conclusion
Choosing the right partner among the available patient panel providers in Poland depends on the specific demands of your research project. For large-scale studies requiring global consistency and advanced analytical capabilities, firms with a global presence offer the necessary infrastructure. However, if your project requires deep, verified insights from niche patient or caregiver populations, selecting a provider with a solid, proprietary panel and a strong focus on data integrity is essential.
We recommend using this scorecard to assess potential partners against your specific criteria, prioritizing those that demonstrate clear, verifiable processes for respondent recruitment and data protection. By focusing on the quality of the proprietary panel and the provider’s commitment to compliance, you can make sure your research delivers actionable and reliable insights for your healthcare initiatives in 2026.
Planning research in Poland? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How to find reliable patient panels for healthcare research in Poland?
To find reliable panels, look for providers that own and manage their own proprietary databases rather than those using third-party sample exchanges. Ask for evidence of their verification processes, including how they validate patient conditions and medical credentials, and check for ISO 27001 and 20252 certifications to protect high data quality and security standards.
What are the best healthcare market research agencies in Poland?
The best agencies depend on the research type. Global Vox Populi is highly specialized for rare-disease and caregiver studies. Stratega Research and AQR Fieldwork excel at local, qualitative fieldwork in Poland. For large-scale global projects, firms like M3 Global Research, Ipsos, and IQVIA provide the necessary scale and technical infrastructure.
How do clinical trial patient recruitment services work in Poland?
Clinical recruitment in Poland involves identifying potential trial participants through verified patient panels or site-based recruitment. Providers screen these individuals against strict inclusion and exclusion criteria, making sure they meet the specific requirements of the study. This process often includes medical history verification and is conducted under strict ethical and regulatory guidelines to protect patient privacy.
Are there specific regulations for patient research in Poland?
Yes, patient research in Poland must comply with the EU General Data Protection Regulation (GDPR) and local Polish data protection laws. Additionally, healthcare research must adhere to ethical guidelines regarding informed consent and, where applicable, the reporting of adverse events to relevant pharmaceutical authorities in line with industry standards.
What is the difference between a patient panel and a clinical trial site?
A patient panel is a database of pre-consented individuals who have opted in to participate in market research and surveys. A clinical trial site, conversely, is a medical facility where actual clinical testing of treatments occurs under the supervision of medical professionals. Panels are used for research insights, while sites are used for patient care and clinical development.
How to reach Polish physicians and patients for pharmaceutical market research?
Reaching these groups is best achieved through specialized healthcare research agencies that maintain proprietary panels. These panels are recruited via professional associations, CME communities, and verified medical registries. By using a provider with a deep, profiled database, you can target specific specialties or patient conditions with high precision.
Which market research companies in Poland specialize in pharma?
Several companies specialize in the Polish pharma market, including Global Vox Populi, which focuses on proprietary patient and caregiver panels, and Stratega Research, which offers deep local qualitative and quantitative expertise. M3 Global Research, IQVIA, and BioStat also provide significant specialized services for pharmaceutical market research and statistical analysis.
How large are the patient panels available for research in Poland?
Panel sizes vary significantly by provider. For example, Global Vox Populi maintains over 1 million patient profiles in Poland across various therapeutic areas. Other agencies like BioStat offer panels exceeding 200,000 respondents. It is important to ask for the number of profiles specific to your required therapeutic area, as general panel size does not guarantee availability for niche conditions.